Oral squamous cell carcinoma (OSCC) has maintained poor prognosis due to its aggressive nature and lack of targetable biomarkers for early and accurate detection. We have developed a targeted MRI contrast agent specific to extradomain-B fibronectin (EDB-FN), an extracellular matrix protein closely associated with tumor aggressiveness. Immunohistochemical analysis revealed strong EDB-FN expression in OSCC with minimal expression in normal tongue tissue. MR molecular imaging with our targeted contrast agent demonstrated the ability for differential contrast enhancement of aggressive OSCC tumors, underscoring the potential for using EDB-FN as a targetable biomarker for precision molecular imaging of OSCC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords